Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI
Purpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval fro...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00215/full |
id |
doaj-b39b9c982ed341649240f6a0a33f26cf |
---|---|
record_format |
Article |
spelling |
doaj-b39b9c982ed341649240f6a0a33f26cf2020-11-25T03:17:20ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-05-01710.3389/fmed.2020.00215507221Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRITing Duan0Hanyu Jiang1Chunchao Xia2Jie Chen3Likunn Cao4Zheng Ye5Yi Wei6Bin Song7Jeong Min Lee8Department of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, Peking Union Medical University Hospital, Peking, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Radiology, College of Medicine, Seoul National University, Seoul, South KoreaPurpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval from the institutional review board and informed consent were obtained for this prospective study. We enrolled 155 patients with liver tumors who underwent pretreatment Gd-EOB-DTPA-enhanced MRI. T1 relaxation time before (T1-pre), 20 min after (T1-post) Gd-EOB-DTPA injection and RLV were measured. The absolute reduction (ΔT1) and reduction rate (ΔT1%) of T1 relaxation time, volume-assisted ΔT1 (ΔT1*RLV) and volume-assisted ΔT1% (ΔT1%*RLV) were calculated accordingly. The correlation of MR parameters with ICG R-15 was determined using Spearman's rank correlation analysis. Patients were classified into the normal liver function (NLF) group if their ICG R-15 levels were <10% or otherwise into the abnormal liver function (ALF) group. Receiver operating characteristic (ROC) analysis was conducted to evaluate the performances of the MR parameters in predicting ALF.Results: T1-post (r = 0.472, P < 0.001), ΔT1 (r = −0.355, P = 0.011), ΔT1% (r = −0.482, P < 0.001), RLV (r = −0.336, P < 0.001), volume-assisted ΔT1 (r = −0.458, P < 0.001) and volume-assisted ΔT1% (r = −0.522, P < 0.001) showed weak to moderate correlation with ICG R-15. The area under the ROC curves (AUROC) of volume-assisted ΔT1 in predicting ALF was 0.777, which was significantly higher than the other parameters (P < 0.05 for all).Conclusions: Combined T1 mapping and RLV on Gd-EOB-DTPA-enhanced MRI can help assess liver function with good diagnostic accuracy in patients with liver tumors before treatment.https://www.frontiersin.org/article/10.3389/fmed.2020.00215/fullGd-EOB-DTPAT1 relaxation timeresidual liver volumemagnetic resonance imagingliver function |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ting Duan Hanyu Jiang Chunchao Xia Jie Chen Likunn Cao Zheng Ye Yi Wei Bin Song Jeong Min Lee |
spellingShingle |
Ting Duan Hanyu Jiang Chunchao Xia Jie Chen Likunn Cao Zheng Ye Yi Wei Bin Song Jeong Min Lee Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI Frontiers in Medicine Gd-EOB-DTPA T1 relaxation time residual liver volume magnetic resonance imaging liver function |
author_facet |
Ting Duan Hanyu Jiang Chunchao Xia Jie Chen Likunn Cao Zheng Ye Yi Wei Bin Song Jeong Min Lee |
author_sort |
Ting Duan |
title |
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI |
title_short |
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI |
title_full |
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI |
title_fullStr |
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI |
title_full_unstemmed |
Assessing Liver Function in Liver Tumors Patients: The Performance of T1 Mapping and Residual Liver Volume on Gd-EOBDTPA-Enhanced MRI |
title_sort |
assessing liver function in liver tumors patients: the performance of t1 mapping and residual liver volume on gd-eobdtpa-enhanced mri |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2020-05-01 |
description |
Purpose: To assess the performance of T1 mapping and residual liver volume (RLV) on Gd-EOBDTPA-enhanced MRI in pretreatment estimation of liver function in patients with liver tumors. Indocyanine green retention rate at 15 min (ICG R-15) was used as a reference standard.Methods: Ethical approval from the institutional review board and informed consent were obtained for this prospective study. We enrolled 155 patients with liver tumors who underwent pretreatment Gd-EOB-DTPA-enhanced MRI. T1 relaxation time before (T1-pre), 20 min after (T1-post) Gd-EOB-DTPA injection and RLV were measured. The absolute reduction (ΔT1) and reduction rate (ΔT1%) of T1 relaxation time, volume-assisted ΔT1 (ΔT1*RLV) and volume-assisted ΔT1% (ΔT1%*RLV) were calculated accordingly. The correlation of MR parameters with ICG R-15 was determined using Spearman's rank correlation analysis. Patients were classified into the normal liver function (NLF) group if their ICG R-15 levels were <10% or otherwise into the abnormal liver function (ALF) group. Receiver operating characteristic (ROC) analysis was conducted to evaluate the performances of the MR parameters in predicting ALF.Results: T1-post (r = 0.472, P < 0.001), ΔT1 (r = −0.355, P = 0.011), ΔT1% (r = −0.482, P < 0.001), RLV (r = −0.336, P < 0.001), volume-assisted ΔT1 (r = −0.458, P < 0.001) and volume-assisted ΔT1% (r = −0.522, P < 0.001) showed weak to moderate correlation with ICG R-15. The area under the ROC curves (AUROC) of volume-assisted ΔT1 in predicting ALF was 0.777, which was significantly higher than the other parameters (P < 0.05 for all).Conclusions: Combined T1 mapping and RLV on Gd-EOB-DTPA-enhanced MRI can help assess liver function with good diagnostic accuracy in patients with liver tumors before treatment. |
topic |
Gd-EOB-DTPA T1 relaxation time residual liver volume magnetic resonance imaging liver function |
url |
https://www.frontiersin.org/article/10.3389/fmed.2020.00215/full |
work_keys_str_mv |
AT tingduan assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT hanyujiang assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT chunchaoxia assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT jiechen assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT likunncao assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT zhengye assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT yiwei assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT binsong assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri AT jeongminlee assessingliverfunctioninlivertumorspatientstheperformanceoft1mappingandresiduallivervolumeongdeobdtpaenhancedmri |
_version_ |
1724631950702936064 |